Industries > Pharma > Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Disease

PUBLISHED: 20 March 2020
PAGES: 200
PRODUCT CODE: PHA0729

Clear
WOOCS 2.2.1

covid-19

The pharma clinical trials services market is expected to grow at a CAGR of 10% in the first half of the forecast period and be worth $150.15bn by 2030.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page report you will receive 51 tables and 110 figures– all unavailable elsewhere.

The 220-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Pharma Clinical Trial Services Market forecasts from 2020-2030

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2030 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis.

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles, Laboratory Corporation of America (LabCorp)
• Pharmaceutical Product Development (PPD)
• Parexel International
• ICON
• INC Research Holdings
• inVentiv Health
• & Other Companies

Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2020-2030: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category